Effect of M8046 on expression of COX-2/PGE2 in spinal cord and DRG in rats with neuropathic pain.
- Author:
	        		
		        		
		        		
			        		Guo-Kun OU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Rui-Xian WANG
			        		
			        		;
		        		
		        		
		        		
			        		Jia-Jia LI
			        		
			        		;
		        		
		        		
		        		
			        		Hong CAO
			        		
			        		;
		        		
		        		
		        		
			        		Qing-Quan LIAN
			        		
			        		;
		        		
		        		
		        		
			        		Jun LI
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Animals; Cyclooxygenase 2; metabolism; Dinoprostone; metabolism; Ganglia, Spinal; drug effects; metabolism; Male; Neuralgia; metabolism; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; antagonists & inhibitors; Spinal Cord; drug effects; metabolism
 - From: Chinese Journal of Applied Physiology 2013;29(2):97-105
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo investigate the effects of glucocorticoid receptor antagonist-M8046 on the behavior and the cyclooxygenase-2/prostaglandin E2( COX-2/PGE2) expression in spinal cord dorsal horn and dorsal root ganglia (DRG) in chronic constrictive injury (CCI) rats.
METHODSOne hundred and forty-four male SD rats were randomly divided into 4 groups, 36 rats in each group: Sham operation group (Sham), chronic constrictive group (CCI), M8046 treated group (M8046) and solvent controlled group (Sc). M8046 3 mg/(kg x d) intraperitoneal injection was given after operation in group M8046. Paw thennal withdrawal (PTWL) and paw mechanical withdrawal threshold (PMWT) of rats were measured on 2 pre-operative and 1, 3, 7, 10, 14 post-operative days. The spinal cord and L15 DRG of the operated side was removed at 3, 7, 14 days after surgery. The change of COX-2 and PGE2 expression was determined by immunohistochemical staining and ELISA separately.
RESULTSPTWL and PMWT in CCI group were significantly lower than those in Sham group on every post-operative day (P < 0.05). PTWL and PMWT in M8046 group were significantly higher than those in CCI group on 7, 10, 14 post-operative day (P < 0.05). In spinal dorsal horn, the level of COX-2 and PGE2 expression in CCI group was significantly higher than that in Sham group (P < 0.05). M8046 could significantly attenuate the activation of COX-2 and PGE2 induced by CCI (P < 0.05). The expression of COX-2 and PGE2 in DRG was similar to that in spinal dorsal horn.
CONCLUSIONThe effects of M8046 ameliorate the CCI-induced neuropathic pain may be related to attenuate the expression of COX-2 and PGE2 in spinal cord and DRG.
 
            